2004
Results Demonstrate the Benefit of An Everolimus Eluting Coronary Stent with Durable Polymer; Investor Briefing Scheduled for 8:00 a.m. ET Tomorrow Indianapolis, Ind., and Washington, D.C. -...
Lifesaving Benefits of Implantable Defibrillators Supported by Multiple Clinical Trials Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today applauds the proposed...
Goal of Study Is To Help Physicians Recognize Patients At Risk of Unexpected Heart Attack Indianapolis, Ind. and Washington, D.C. - Guidant Corporation (NYSE: GDT) today announced plans to conduct...
Highly Deliverable New Stent Broadens Guidant''s Market-Leading Metallic Stent Portfolio Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced U.S. Food and...
International Trial Will Study Unnecessary Pacing in Heart Failure Patients Indianapolis, Ind. And St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced that it has completed...
Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for the company''s...
National Registry Will Now Focus on Patient Identification and Treatment Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE:GDT) today announced that its ADVANCENTSM national...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today commended the Centers for Medicare & Medicaid Services (CMS) for its intent to expand coverage of carotid artery...
Federal Circuit Court of Appeals Returns the Case to Lower Court to Determine Infringement and Damages Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it won its appeal...